Form EFFECT Mersana Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 8, 2026 |
| Accession Number: | 0001104659-26-001281 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U-topia Launches Public Beta as Global Builders Gather for U-Hackathon
- Best Altcoin to Buy: Arbitrum Adds USDG and Weighs a 100M ARB Proposal as Remittix Tests Bank Payment Routes
- Best Crypto To Buy Now: Alaya Governance Token Tops $100M Volume as AlphaPepe’s $3M Presale Eyes Binance
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share